von Hippel-Lindau peptide vaccine

von Hippel-Lindau peptide vaccine information and resources from the National Cancer Institute

NCI Thesaurus | von Hippel-Lindau peptide vaccine

A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide vaccine may stimulate a cytotoxic T cell response against tumor cells expressing the VHL tumor-associated protein. NCI Thesaurus | von Hippel-Lindau peptide vaccine

A cancer vaccine composed of peptides derived from a tumor-associated protein encoded by a mutated Von Hippel-Lindau (VHL) oncogene. VHL peptide vaccine may stimulate a cytotoxic T cell response against tumor cells expressing the VHL tumor-associated protein.

von Hippel-Lindau peptide vaccine -->

Home | About | Search topics | Cancers | Treatment | Medications
Onconews provides free news and resources on cancer-related topics.

Copyright onconews.org 2005-2006.
All Rights Reserved.
Google
 
Web onconews.org